Posted 3/25/2024
Scientists and clinicians whose discoveries have shaped the understanding of HIV disease will provide updates on the...
Posted 2/22/2024
There are many paths for women to travel to find success in science. That was a crucial theme conveyed by the four...
Posted 2/7/2024
Frederick National Laboratory researchers identified a vitamin A derivative (retinoid) that when combined with a...
All News
Frederick National Laboratory, National Cancer Institute of Mexico to Offer Training Fellowships
Posted 6/26/2018FREDERICK, Md. -- The Frederick National Laboratory for Cancer Research will extend its scientific mentoring across international borders for the first time by offering postdoctoral research fellowships to scientists under an agreement with the National Cancer Institute of Mexico (INCan).
Under a three-year Memorandum of Understanding, the two institutions will…
Frederick National Laboratory Scientists to Present Advanced Technologies in Cancer Research
Posted 6/7/2018FREDERICK, Md. -- Hundreds of science and business professionals are expected to attend the second annual Technology Showcase at the Frederick National Laboratory for Cancer Research, scheduled for June 13.
The event will feature technologies being developed at the National Cancer Institute (NCI) and the Frederick National Laboratory to encourage startup company formation…
Hood College, Frederick National Laboratory Will Renew Popular Scientific Symposium
Posted 5/20/2018FREDERICK, Md. -- Hood College and the Frederick National Laboratory for Cancer Research have partnered to cohost an annual scientific symposium in the tradition of the landmark Oncogene Meeting, a national fixture in Frederick for more than 20 years.
A recently signed, three-year Memorandum of Understanding between the two institutions also will expand research and…
New Nanoparticle Inhibits Growth of Pancreatic Cancer in Mice
Posted 5/9/2018FREDERICK, Md. -- In early experiments, a targeted nanomedicine has safely halted the growth of pancreatic cancer — the deadliest of solid tumors — and prevented its most dangerous feature, metastasis, the spread of tumor cells.
Using a mouse model of the disease, scientists at Georgetown University and the Frederick National Laboratory for Cancer Research developed a novel…
Numerate Intends to Join ATOM Consortium to Rapidly Accelerate Preclinical Drug Development
Posted 4/16/2018SAN FRANCISCO – Computational drug design company Numerate has signed a letter of intent to join an open consortium of scientists staffed from two U.S. national laboratories, industry, and academia working to transform drug discovery and development into an approach that is rapid, integrated and with better patient outcomes.
Accelerating Therapeutics for Opportunities in…
Frederick National Laboratory Staff Advance Genomic Data Commons Capabilities
Posted 3/15/2018FREDERICK, Md. -- A recent study that examined how mutations of a certain gene could affect clinical management of glioma, one of the most common types of primary brain tumors, is one of the first examples of the Genomic Data Commons’ impact on cancer research.
Launched in 2016 as part of the Precision Medicine Initiative, the National Cancer Institute’s Genomic Data…
Nanotechnology Characterization Laboratory Unveils New Technical Services for Drug Developers
Nanotechnology Characterization LaboratoryPosted 3/8/2018FREDERICK, Md. -- Drug developers now have access to a shared analytical technology, developed and provided by the Frederick National Laboratory for Cancer Research, that helps fine-tune nanomedicine formulations and overcomes a key hurdle on the path toward Food and Drug Administration approval of effective new therapies and generic versions of nanomedicines.
The…
Frederick National Laboratory and Georgetown University Launch Research and Education Collaboration
Posted 2/27/2018FREDERICK, Md. -- A new collaboration established between Georgetown University and the Frederick National Laboratory for Cancer Research aims to expand both institutions’ research and training missions in the biomedical sciences.
Representatives from Georgetown and the Frederick National Laboratory signed a memorandum of understanding that paves the way for appointments…
First-in-Class Drug Being Tested for Breast Cancer May Also Work in Lung Cancer
Posted 2/7/2018FREDERICK, Md. -- A novel agent now being tested in human clinical trials of breast and other cancers may also prove to be a candidate for treating lung cancer, the No. 1 cancer killer worldwide.
The targeted treatment uses a new approach to destroy cancer cells. It attacks the basic machinery that malignant cells use to reproduce themselves. The machinery malfunctions and…
Study IDs Genetic Markers that Speed AIDS Progression
Posted 1/25/2018A study published in the journal Science sheds new light on how a set of human genes can accelerate progression of AIDS-related illness in people living with HIV who are not on treatment.
South African scientists led the international research team, which included Frederick National Laboratory scientists, that involved 9,763 people with HIV in the United States and South…
Media Inquiries
For all media related questions please contact:
Mary Ellen Hackett
Manager, Communications Office